Nicotinic Acid Adenine Dinucleotide Phosphate: A New Ca2+ Releasing Agent in Kidney
JINGFEI CHENG*,
AHAD N. K. YUSUFI*,
MICHAEL A. THOMPSON*,
EDUARDO N. CHINI and
JOSEPH P. GRANDE*
*Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester,
Minnesota. Department of Anesthesiology, Mayo Clinic, Rochester,
Minnesota.
Correspondence to Dr. Joseph P. Grande, Department of Laboratory Medicine,
Mayo Clinic and Foundation, Rochester, MN 55905. Phone: 507-284-6988; Fax:
507-284-3757; E-mail:
grande.joseph{at}mayo.edu
Abstract. Nicotinic acid adenine dinucleotide phosphate (NAADP),a
molecule derived from ß-NADP, has been shown to triggerCa2+
release from intracellular stores of invertebrate eggsand mammalian cell
microsomes. NAADP-induced Ca2+ release occursthrough a mechanism
distinct from that of inositol-1,4,5-trisphosphateor cyclic
ADP-riboseelicited Ca2+ release. This studyinvestigated
whether NAADP can be synthesized in rat kidney.Extracts from glomeruli,
mesangial cells, and papilla have highNAADP synthetic capacities. Conversely,
synthesis of NAADP inkidney cortex was almost undetectable. Furthermore,
9-cis-retinoicacid significantly up-regulated NAADP synthesis in
mesangialcells. Authenticity of NAADP biosynthesis in glomeruli was affirmed
byHPLC analysis. NAADP stimulated Ca2+ release from mesangialcell
microsomes through a pathway distinct from that of
inositol-1,4,5-trisphosphateor cyclic ADP-ribose. NAADP-triggered
Ca2+ release may playan important role in regulation of renal
function.
Release of Ca2+ from intracellular stores is an important
componentof several signaling pathways
(1,2).
Two major mechanisms ofintracellular Ca2+ release are well known:
(1) the inositol-1,4,5,-trisphosphate(IP3)-triggered
Ca2+ release
(1,2)
and (2) the so-called Ca2+-induced Ca2+
-release system, mediated by the ryanodine receptor/channeland activated by
the endogenous nucleotide cyclic ADP-ribose(cADPR)
(3,4,5,6,7).
In addition to Ca2+ release induced bycADPR and IP3,
nicotinic acid adenine dinucleotide phosphate(NAADP) was recently
characterized as a potent stimulator ofintracellular Ca2+ release
in invertebrates and mammalian cells
(7,8,9,10,11,12,13,14,15).
NAADP-inducedCa2+ release was first demonstrated in sea urchin
eggs
(7,8,9),
wherenanomolar concentrations trigger Ca2+ release via a mechanism
thatdiffers in many ways from cADPR and IP3
(7,8,9,10,11,12,13,14,15).
cADPR is synthesized by the enzyme ADP-ribosyl-cyclase (ADPR-cyclase)
(7).In mammalian tissues, the
majority of the enzymatic activityis catalyzed by lymphocyte antigen CD38,
also identified asCD38 ADPR-cyclase
(16,17).
Recently, we described that in kidneyparenchyma and its components, only
glomeruli are endowed witha high capacity for cADPR synthesis
(18). Furthermore, we
demonstratedthat cADPR synthesis and Ca2+ release are present in
renal mesangialcells
(18,19).
We have proposed that cADPR may play an importantsignaling role in this cell
type
(18,19).
In contrast with the metabolism of cADPR, far less is knownabout synthesis
of NAADP in mammalian tissues. We previouslyshowed that NAADP synthesis is
present in several rat tissues,including brain, heart, liver, and spleen
(20). However, weobserved no
detectable synthesis of NAADP in rat kidney
(20).In view of the recent
finding of NAADP-induced Ca2+ releasein pancreatic acinar cells
and brain microsomes
(21,22),
weinvestigated NAADP synthesis in extracts from major zones ofrat kidney
parenchyma as well as isolated glomeruli and mesangialcells. Here we report
that in extracts of rat cortex, NAADPsynthesis was almost undetectable. In
contrast, high capacitysynthesis of NAADP was found in glomeruli, mesangial
cells,and papilla. This new insight provides important informationabout
synthesis of NAADP in kidney parenchyma and reveals thatglomeruli and renal
papilla are endowed with a high capacityfor NAADP synthesis. We suggest a
role for NAADP signaling inregulation of renal function.
Tissues were harvested from adult male Sprague-Dawley rats (250to 350 g
body wt) and killed under cocktail anesthesia (50%xylazine, 20 mg/ml and 50%
Ketalar, 100 mg/ml; 0.1 ml cocktail/100g body wt). Kidney and liver were
quickly dissected, chilled,and minced in ice-cold solution containing 0.25 M
sucrose, 20mM Tris-HCl (pH 7.2). Tissues were Dounce homogenized (1:4;
wt/vol)using 8 to 10 strokes and centrifuged at 4000 x rpm for 10 min
at4°C. The supernatant, denoted further as extract, was collectedand
used for determination of enzymatic synthesis of NAADP.The protein content
was measured by the method of Lowry et al.
(23).
Preparation of Glomeruli
Glomeruli were prepared by sequential sieving as described previously
(24).Briefly, rats were
anesthetized by intraperitoneal injectionof cocktail, and the kidneys were
perfused (10 ml/min) in situwith prewarmed (37°C) Hanks balanced
salt solution followedby ice-cold Hanks balanced salt solution. Cortical
tissue wasfinely minced before passing through a stainless steel sieve
(250-µmpore size). The resulting suspension was passed several times
thougha 22-gauge needle to ensure complete dispersion and sequentiallysieved
through nylon mesh of 390-, 250-, and 211-µm poreopenings. The cortical
suspension was then passed over a 60-µmsieve to collect the glomeruli.
Purity of glomeruli was evaluatedby microscopic examination, and counting
preparations contained>95% glomeruli
(24).
Synthesis of NAADP
NAADP was synthesized by incubating rat kidney homogenates (1mg/ml) or
membrane fraction of mesangial cells (0.3 mg/ml) with0.2 mM ß-NADP, 7 mM
nicotinic acid at 37°C, in a mediumcontaining 0.25 M sucrose and 20 mM
Tris HCI (pH 6.5) for 60min, or as specified in the Results section. The
content ofNAADP was determined using a sea urchin egg homogenate
Ca2+release bioassay
(7,25).
Sea Urchin Egg Homogenate Bioassay
Homogenates from sea urchin eggs (Lytechinus pictus) were prepared
asdescribed previously (7).
Frozen homogenates were thawed ina 17°C water bath and diluted to 1.25%
in a medium containing2 u/ml creatine kinase, 4 mM phosphocreatine, 1 mM ATP,
3 µMfluo-3. Fluo-3 fluorescence was monitored at 490 nm excitationand 535
nm emission in a 250-µl cuvette at 17°C witha circulating water bath
and continuously mixed with a magneticstirring bar, using a
spectrofluorometer (F-2000; Hitachi, Ltd.,Tokyo, Japan)
(7,25).
Mesangial Cells
Mesangial cells were grown in cell culture from glomeruli thatwere
isolated from adult Sprague-Dawley rats by differentialsieving
(26). Cell outgrowths were
characterized as mesangialcells by positive immunohistochemical staining for
vimentinand smooth muscle-specific actin and by negative staining for
cytokeratins,factor VIII-related antigen, and common leukocyte antigen.
Mesangialcells were harvested and membrane fraction was prepared as described
previously(27).
Preparation of NAADP
Authentic NAADP was synthesized from ß-NADP and nicotinicacid via the
base-exchange enzymatic reaction catalyzed by brainNAD-glycohydrolase
(7,28).
The nucleotides were purified byanion-exchange HPLC
(7). NAADP in all experiments
was at least97% pure as determined by HPLC analysis.
45Ca2+ Release from Microsomes
Freshly prepared microsomes (approximately 100 µg of protein)were
passively loaded by incubating for 3 h at room temperature(21°C) in a
medium containing 100 mM NaCl, 25 mM HEPES (pH7.2), 1 mM CaCl2,
and 1 µC of 45Ca2+. Release of
45Ca2+from loaded microsomes was initiated by 10-fold
dilution ofmicrosomal suspension with a buffer containing 100 mM NaCl,1 mM
ethyleneglycol-bis(ß-aminoethyl ether)-N,N'-tetraacetic
acid,1 mM MgCl2, and 25 mM HEPES (pH 7.2)
(19). After 10 s, the
suspensionwas further diluted in the same medium without or with 10 µM
NAADP(final dilution 50-fold). 45Ca2+ efflux was
stopped 90 s afterthe second dilution by test agents, and the
45Ca2+ retainedin microsomes was separated from free
45Ca2+ by a rapid filtrationtechnique using Whatman
GF/B filters. The filters were rinsedthree times with a solution containing
100 mM NaCl, 1 mM ethyleneglycol-bis(ß-aminoethyl
ether)-N,N'-tetraaceticacid, 4 mM MgCl2, and 25 mM
HEPES (pH 7.2). The 45Ca2+ retainedin microsomes was
determined by liquid scintillation counting.
L. pictus was obtained from Marinus, Inc. (Long Beach, CA).Fluo-3
was purchased from Molecular Probes (Eugene, OR). Allother reagents, of the
highest purity grade available, weresupplied by Sigma Co. (St. Louis,
MO).
Statistical Analyses
When appropriate, results were evaluated statistically by t
test.
NAADP Synthesis in Kidney Parenchyma
We determined NAADP synthesis in extracts of renal cortex, medulla,and
papilla. We found that papilla and, to a lesser extent,medulla were able to
synthesize NAADP from ß-NADP andnicotinic acid
(Figure 1). The rate of
synthesis of NAADP inpapilla is comparable to that observed in liver. In
contrast,kidney cortex has a limited capacity for synthesis of NAADP
(Figure 1).The amount of NAADP
synthesized in cortex is near the lowerlimit of detection of the sea urchin
egg homogenate bioassay(7). We
also observed that with time the NAADP synthesized washydrolyzed in kidney
tissues more rapidly than in liver (Figure
1).This observation is compatible with our previous observation
thatrat kidney has a higher rate of NAADP hydrolysis than othertested
tissues (20).
Figure 1. Biosynthesis of nicotinic acid adenine dinucleotide phosphate (NAADP) by
rat kidney homogenates. Rat kidney and liver homogenates (1 mg/ml) were
incubated at 37°C in a medium containing 7 mM nicotinic acid, 0.2 mM
ß-NADP, and 20 mM Tris HCl (pH 6.5) for 7 min, 15 min, 30 min, and 60
min. Aliquots (3 µl) of the assay media were tested for Ca2+
release activity using the sea urchin egg homogenate bioassay. NAADP content
was determined from calibration curve of the sea urchin egg homogenate
Ca2+ release bioassay. The calibration curve was generated by
responses to known concentration of authentic purified NAADP standards. [UNK],
liver; , papilla; , medulla; , cortex; ,
glomeruli.
Synthesis of NAADP in Glomeruli
In view of the fact that synthesis of other signaling moleculescan be
distinctly localized in specific segments of the nephron
(29),we determined NAADP
synthesis in extracts of isolated glomeruli.Unlike extracts of renal cortex,
glomeruli have a high capacityfor NAADP synthesis
(Figure 1). We further
characterized theNAADP synthesis in glomeruli. The synthesis of NAADP was
highlydependent on the concentration of precursor molecules, including
ß-NADP(Figure 2A) and
nicotinic acid (Figure 2B). In
addition, weobserved a pH dependence for the synthesis of NAADP in glomeruli
(Figure 3).Synthesis of NAADP
in glomeruli is increased by acidificationof the media; the optimal pH is
approximately 4 (Figure 3).
SimilarpH dependence for synthesis of NAADP has been demonstrated inother
systems, including sea urchin egg homogenates
(25). Furthermore,the
authenticity of NAADP generated by glomeruli was affirmedby HPLC analysis
(Figure 4).
Figure 2. Dose-dependence of ß-NADP and nicotinic acid on NAADP synthesis in rat
kidney. (A) Dose-dependence of ß-NADP. Rat glomeruli homogenate (1 mg/ml)
was incubated with 7 mM nicotinic acid and different concentrations of
ß-NADP as substrates for 15 min, and the NAADP content was determined
using the sea urchin egg homogenate bioassay. (B) Dose-dependence of nicotinic
acid. Renal LLC-PK1 cell homogenate (1 mg/ml) was incubated with 0.2 mM
ß-NADP and different concentrations of nicotinic acid for 15 min, and the
NAADP content was determined by sea urchin egg homogenate bioassay.
Figure 3. pH-dependence of NAADP production in rat glomeruli. Glomeruli homogenate (1
mg/ml) was incubated with 0.2 mM ß-NADP and 7 mM nicotinic acid in
different pHs for 15 min. NAADP content was determined by sea urchin egg
homogenate bioassay.
Figure 4. HPLC determination of NAADP. Rat glomeruli homogenate (1 mg/ml) was
incubated with 0.2 mM ß-NADP and 7 mM nicotinic acid in a 20 mM Tris HCl
buffer (pH 4.0) at 37°C for 1 h. The reaction was stopped by addition of
equal volume of cold acetone and centrifuged 2000 x g for 2
min. After acetone evaporation, the supernatant was subjected to
anion-exchange HPLC analysis. The figure shows HPLC analysis of incubate at
time 0 min ([UNK]) and 60 min ([UNK]) of incubation.
Synthesis of NAADP in Mesangial Cells
We further explored synthesis of NAADP in glomerular mesangialcells. We
observed that mesangial cells showed a high capacityfor synthesis of NAADP
(Figure 5). In vascular smooth
musclecells and in LLC-PK1 cells, we previously showed that cADPRsynthesis
is induced by retinoic acid
(27,30).
Here we observedthat incubation of mesangial cells with retinoic acid
promotesa threefold increase in the initial rate of NAADP synthesisin these
cells (Figure 5). This is the
first described upregulationof NAADP synthesis in mammalian cells. We also
observed a similarstimulation of NAADP synthesis by retinoic acid in LLC-PK1
andHL-60 cells (data not shown).
Figure 5. Synthesis of NAADP in mesangial cells. Mesangial cells were incubated with
([UNK]) or without () 1 µM 9-cis retinoic acid for 24 h, and
membrane fraction was prepared as described in the Materials and Methods
section. Membrane fraction of mesangial cells (0.3 mg/ml) was incubated at
37°C with 0.2 mM ß-NADP and 7 mM nicotinic acid for 5 min, 10 min, 30
min, and 60 min. The amount of NAADP produced was measured by sea urchin egg
homogenate Ca2+ release bioassay.
NAADP Induces Ca2+ Release from Mesangial Cell
Microsomes
We also determined whether glomerular mesangial cells possessan
NAADP-sensitive Ca2+ release mechanism. NAADP elicited
Ca2+release from rat mesangial cell microsomes in a dose-dependent
manner,with maximal Ca2+ release observed after administration of
10µM NAADP (Figure 6).
Heparin, an IP3 receptor antagonist,and 8-bromo-cADPR and
ruthenium red, selective inhibitors ofcADPR-mediated Ca2+ release
through the ryanodine receptor/channel,had no effect on Ca2+
release activity triggered by NAADP (Figure
7).On the basis of these findings, it seems that NAADP promotes
Ca2+release from mesangial cell microsomes through a pathway
functionallydistinct from that of IP3 or cADPR. The magnitude and
time courseof NAADP-induced Ca2+ release was similar to that of
IP3-mediatedCa2+ release in mesangial cell microsomes
(Figure 8).
Figure 6. Dose dependency of NAADP-induced 45Ca2+ release.
Preloaded microsomes were incubated with different concentrations of NAADP,
and 45Ca2+ release was measured as described in the
Materials and Methods section.
Figure 7. Effect of NAADP and inhibitors of ryanodine receptor/channel and
inositol-1,4,5,-trisphosphate (IP3) receptor on
45Ca2+ release from preloaded microsomes.
Ca2+ release was performed as described in the Materials and
Methods section. , control, no additions; [UNK], 10 µM NAADP; [UNK],
10 µM NAADP with 20 µM 8-br-cADPR (ryanodine channel inhibitor); ,
10 µM NAADP with 8 µM heparin (IP3 receptor blocker); [UNK],
10 µM NAADP with ruthenium red (RR; ryanodine channel inhibitor).
Figure 8. Time courses of 45Ca2+ release induced by NAADP and
IP3. Passively loaded microsomes were incubated with 10 µM NAADP
([UNK]) or 8 µM IP3 () for various time periods, and
45Ca2+ release was measured as described in the
Materials and Methods section.
It has been previously shown that NAADP is synthesized in mammaliantissues
(20,25,27,30,31)
and can trigger Ca2+ release from intracellularstores in
invertebrate and vertebrate cells
(7,8,9,21,22),
suggestingthat NAADP-induced Ca2+ release may be widespread and
thus contributeto the complexity of intracellular Ca2+ signaling.
We previouslyreported that some rat tissues, including brain, heart, liver,
andspleen but not whole kidney, can synthesize NAADP
(20). Theresults of the
present study provide novel fundamental informationregarding the metabolism
of NAADP in kidney. We found that glomeruliand papilla showed a very high
capacity for NAADP synthesis,which was comparable to that observed in liver
(Figure 1). Incontrast,
considerably less NAADP synthesis was found in extractsfrom renal cortex
(Figure 1). Because glomeruli
constitute only5% of renal cortical mass
(32), the extremely low
capacity forNAADP synthesis in cortex compared with glomeruli may be dueto
the great diversity of cell populations in kidney. We previouslyreported that
although limited amounts of cADPR were formedin whole kidney cortical tissue,
high activity of cADPR synthesiswas found in isolated glomeruli
(18).
Although the role of NAADP system in kidney papilla is not known,it is
important to note that regulation of intracellular Ca2+is an
important component in signal transduction in inner medullarycollecting duct
(IMCD) cells from papilla. It was recently revealedin IMCD cells from rat
papilla that Ca2+ dependence is a uniquephenomenon for stimulation
of sorbitol efflux during hypotonicshock
(33). It has also been
reported that during hypotonicshock, intracellular Ca2+ is
transiently elevated in IMCD cellsand the increase seems to involve an
initial Ca2+ release fromintracellular stores followed by a rapid
Ca2+ influx from theextracellular medium
(34). Although the role of the
NAADP-Ca2+releasing system in papilla is speculative, it should be
furtherinvestigated.
With respect to the site of NAADP synthesis in glomeruli, wefound that
extracts from mesangial cells grown in primary cultureshowed a significant
rate of NAADP synthesis (Figure
5). Mesangialcells are specialized pericytes in glomeruli and are
essentialfor maintenance and regulation of glomerular function
(35,36,37).
Contractilityand other functions of mesangial cells are mainly regulatedby
Ca2+ released from intracellular stores
(35,36,37,38).
Numerousstimuli modulate the function of mesangial cells by bindingto
requisite receptors in the plasma membrane and via the
IP3-Ca2+release pathway
(38). The presence of
IP3 receptors in mesangialcells has been documented
(39). More recent, we
confirmed thatryanodine receptor/channel are also expressed in mesangial
cellsby [3H]-ryanodine binding to microsomal fractions of
mesangialcells and by Western blot analysis
(19). In addition, we observed
thatthe 45Ca2+ release from preloaded mesangial cell
microsomeswas greatly stimulated by cADPR
(19) and NAADP. These data
suggestthat in addition to the IP3-Ca2+ release
pathway, cADPR- andNAADP-induced Ca2+ release signaling pathways
may regulate thefunction of mesangial cells.
This study also showed that kidney extracts have a higher rateof NAADP
degradation than other rat tissues. Various phosphomonoesterasesand
phosphodiesterases may inactivate NAADP
(20). Extraordinarilyhigh
inactivating activity of kidney extract may be due to highcontent and
activity of alkaline phosphatase
(40) and acid phosphatase
(41)in proximal tubules.
It has been shown that the enzyme responsible for both cADPRand NAADP
production has a marked pH dependence, favoring cADPRformation at a higher pH
and NAADP formation at a lower pH
(25).In our studies, we found
that the maximal NAADP formation wasobserved at pH 4
(Figure 3). Although NAADP
synthesis at pH7 is relatively low compared with its synthesis at more acid
pH,it was significantly higher than cADPR synthesis at pH 7 (7nmol NAADP/mg
protein per min compared with 0.13 nmol cADPR/mgprotein per min)
(18), thus indicating that
although the optimalcondition for NAADP synthesis is in the acidic cellular
compartments,NAADP production can occur in the cytosol as well.
In conclusion, our results provide strong evidence that NAADPcan be
synthesized and inactivated in kidney and that NAADPformation is localized in
glomeruli and papilla. Furthermore,we found that NAADP induces
Ca2+ release from mesangial cellmicrosomes through a pathway that
is functionally distinct fromthat of IP3 or cADPR. We provide
preliminary evidence that NAADPproduction may be stimulated by extracellular
stimuli, retinoicacid in particular. These data together suggest that the
NAADP-Ca2+release system may play a role in regulation of renal
function.Future studies to determine mechanisms that underlie NAADP
productionwill define the role of this calcium signaling system in renal
pathophysiologicstates.
Acknowledgments
This research was supported in part by the American Heart Association
(Minnesotaaffiliate), Grant-in-Aid to E.N.C., NIH Grants DK-30597 and
DK-16105,and by Mayo Foundation. The authors thank Henry Walker and Dr.
ClaudiaC. S. Chini for critical reading of the manuscript. The excellent
secretarialassistance of Cherish Grabau is appreciated.
Berridge MJ: The biology and medicine of calcium signaling.
Mol Cell Endocrinol 98:119
-124, 1994[Medline]
Clapham DE: Calcium signaling. Cell80
: 259-268,1995[Medline]
Coranado R, Morrissette J, Sukhareva M, Vaughan DM: Structure and
function of ryanodine receptors. Am J Physiol266
: C1485-C1504,1994[Abstract/Free Full Text]
Lee HC: Cyclic ADP-ribose: A calcium mobilizing metabolite of
NAD+. Mol Cell Biochem138
: 229-235,1994[Medline]
Galione A, White A: Ca2+ release induced by cyclic
ADP-ribose. Trends Cell Biol 4:431
-436, 1994[Medline]
Dousa TP, Chini EN, Beers KW: Adenine nucleotide diphosphates:
Emerging second messengers acting via intracellular Ca2+ release.
Am J Physiol 271:C1007
-C1024, 1996[Abstract/Free Full Text]
Chini EN, Beers KW, Dousa TP: Nicotinate adenine dinucleotide
phosphate (NAADP) triggers a specific calcium release system in sea urchin
eggs. J Biol Chem 270:3216
-3223, 1995[Abstract/Free Full Text]
Lee HC, Aarhus RA: A derivative of NADP mobilizes Ca2+
stores insensitive to inositol triphosphate and cyclic ADP-ribose.
J Biol Chem 270:2152
-2157, 1995[Abstract/Free Full Text]
Chini EN, Beers KW, Chini CS, Dousa TP: Specific modulation of
cyclic ADP-ribose-induced Ca2+ release by polyamines. Am
J Physiol 269:C1042
-C1047, 1995[Abstract/Free Full Text]
Perez-Terzic CM, Chini EN, Shen SS, Dousa TP, Clapham DE:
Ca2+ release triggered by nicotinate adenine dinucleotide phosphate
in intact sea urchin eggs. Biochem J312
: 955-959,1995
Chini EN, Dousa TP: Nicotinate adenine dinucleotide
phosphate-induced Ca2+ release does not behave as a Ca2+
-induced Ca2+ - release system. Biochem J316
: 709-711,1996
Chini EN, Liang M, Dousa TP: Differential effect of pH upon
cyclic-ADP-ribose and nicotinate adenine dinucleotide phosphate-induced
Ca2+ release system. Biochem J335
: 499-504,1998
Genazzani AA, Galione A: Nicotinic acid adenine dinucleotide
phosphate mobilizes Ca2+ from a thapsigargin-insensitive pool.
Biochem J 315:721
-725, 1996
Genazzani AA, Galione A: A Ca2+ release mechanism gated
by the novel pyridine nucleotide NAADP. Trends Pharmacol
Sci 18: 108-110,1997[Medline]
Graeff RM, Podein RJ, Aarhus R, Lee HC: Magnesium ions but not ATP
inhibit cyclic ADP-ribose-induced Ca2+ -release. Biochem
Biophys Res Commun 206:786
-791, 1995[Medline]
Howard M, Grimaldi JC, Brazan JF, Lund FE: Formation and hydrolysis
of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38.
Science 262:1056
-1059, 1993[Abstract/Free Full Text]
Kukimoto I, Hoshino S, Kontani K, Inageda K, Nishina H, Takahashi
K, Katada T: Stimulation of ADP-ribosyl cyclase activity of the cell surface
antigen CD38 by zinc ions resulting from inhibition of its NAD+
glycohydrolase activity. Eur J Biochem239
: 177-182,1996[Medline]
Chini EN, Klener P Jr, Beers KW, Chini CS, Grande JP, Dousa TP:
Cyclic ADP-ribose metabolism in rat kidney: High capacity for synthesis in
glomeruli. Kidney Int 51:1500
-1506, 1997[Medline]
Yusufi ANK, Thompson MA, Walker HJ, Dousa TP: Ryanodine
receptor/channel (RyR) for Ca2+ release in rat mesangial cells (MC)
[Abstract]. J Am Soc Nephrol10
: 486A,1999
Chini EN, Dousa TP: Enzymatic synthesis and degradation of
nicotinate adenine dinucleotide phosphate (NAADP), a Ca2+ -
releasing agonist, in rat tissue. Biochem Biophys Res
Commun 209:167
-174, 1995[Medline]
Cancela JM, Churchill GC, Galione A: Coordination of
agonist-induced Ca2+ -signaling patterns by NAADP in pancreatic
acinar cells. Nature 398:74
-76, 1999[Medline]
Bak J, White P, Timar G, Missiaen L, Genazzani AA, Galione A:
Nicotinic acid adenine dinucleotide phosphate triggers Ca2+ release
from brain microsomes. Curr Biol9
: 751-754,1999[Medline]
Lowry OH, Rosebrogh NJ, Farr AL, Randall RJ: Protein measurement
with the Folin phenol reagent. J Biol Chem193
: 265-275,1951[Free Full Text]
Chini CS, Chini EN, Williams JM, Matousovic K, Dousa TP: Formation
of reactive oxygen metabolites in glomeruli is suppressed by inhibition of
cAMP phosphodiesterase isozyme type-IV. Kidney Int46
: 28-36,1994[Medline]
Aarhus R, Graeff RM, Dickey DM., Walseth TF, Lee HC: ADP-ribosyl
cyclase and CD38 catalyze the synthesis of a calcium mobilizing metabolite
from NADP+. J Biol Chem270
: 30327-30333,1995[Abstract/Free Full Text]
Matousovic K, Grande JP, Chini CS, Chini EN, Dousa TP: Inhibitors
of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress
proliferation of rat mesangial cells. J Clin Invest96
: 401-410,1995
Beers KW, Chini EN, Dousa TP: All-trans-retinoic acid
stimulate synthesis of cyclic ADP-ribose in renal LLC-PK1 cells.
J Clin Invest 95:2385
-2390, 1995
Morel F, Doucet A: Hormonal control of kidney functions at the cell
level. Physiol Rev 66:377
-468, 1986[Free Full Text]
De Toledo FGS, Cheng J, Dousa TP: Retinoic acid and
triiodothyronine stimulate ADP-ribosyl cyclase activity in rat vascular smooth
muscle cells. Biochem Biophys Res Commun238
: 847-850,1997[Medline]
Liang M, Chini EN, Cheng J, Dousa TP: Synthesis of NAADP and cADPR
in mitochondria. Arch Biochem Biophys371
: 317-325,1999[Medline]
Pfaller W, Rittinger M: Quantitative morphology of the rat kidney.
Int J Biochem 12:17
-22, 1980[Medline]
Bevan C, Theiß C, Kinne RKH: Roles of Ca2+ in
sorbitol release from rat inner medullary collecting duct (IMCD) cells under
hypoosmotic stress. Biochem Biophys Res Commun170
: 563-568,1990[Medline]
Mooren FC, Kinne RKH: Intracellular calcium in primary cultures of
rat renal inner medullary collecting duct cells during variations of
extracellular osmolality. Pflügers
Arch 427:463
-472, 1994[Medline]
Bonventre JV: Calcium and calcium-related signaling pathways in
glomerular mesangial cells. Clin Exper Pharmacol
Physiol 23:65
-70, 1996[Medline]
Stockand JD, Sansom SC: Glomerular mesangial cells:
Electrophysiology and regulation of contraction. Physiol
Rev 78: 723-744,1998[Abstract/Free Full Text]
Schlondorff D: Roles of the mesangium in glomerular function.
Kidney Int 49:1583
-1585, 1996[Medline]
Ardaillou R, Ronco P, Rondeau E: Biology of renal cells in culture.
In: The Kidney, 5th Ed., edited by Brenner BM,
Philadelphia, W.B. Saunders, 1996, pp99
-192
Monkawa T, Hayashi M, Miyawaki A, Sukiyama T, Yamamoto-Hino M,
Hasegawa M, Furuichi T, Mikoshiba K, Saruta T: Localization of inositol
1,4,5-trisphosphate receptors in the rat kidney. Kidney
Int 53: 296-301,1998[Medline]
Kempson SA, Kim JK, Northrup TE, Knox FG, Dousa TP: Alkaline
phosphatase in adaptation to low dietary phosphate intake. Am J
Physiol 237:E465
-E473, 1979
Le Hir ML, Dubach UC: Distribution of acid hydrolases in the
nephron of normal and diabetic rats. Int J Biochem12
: 41-45,1980[Medline]
Received for publication February 15, 2000.
Accepted for publication June 15, 2000.
This article has been cited by other articles:
M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, J. Cheng, H. K. H. Keryakos, K. A. Nath, and J. P. Grande Signaling pathways modulated by fish oil in salt-sensitive hypertension
Am J Physiol Renal Physiol,
June 1, 2008;
294(6):
F1323 - F1335.
[Abstract][Full Text][PDF]
S. Soares, M. Thompson, T. White, A. Isbell, M. Yamasaki, Y. Prakash, F. E. Lund, A. Galione, and E. N. Chini NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C227 - C239.
[Abstract][Full Text][PDF]
J. Cheng, M. M. D. Encarnacion, G. M. Warner, C. E. Gray, K. A. Nath, and J. P. Grande TGF-{beta}1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process
Am J Physiol Cell Physiol,
October 1, 2005;
289(4):
C959 - C970.
[Abstract][Full Text][PDF]
J. Cheng, M. A. Thompson, H. J. Walker, C. E. Gray, M. M. Diaz Encarnacion, G. M. Warner, and J. P. Grande Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4
Am J Physiol Renal Physiol,
November 1, 2004;
287(5):
F940 - F953.
[Abstract][Full Text][PDF]
I. L. O. Buxton Regulation of Uterine Function: a Biochemical Conundrum in the Regulation of Smooth Muscle Relaxation
Mol. Pharmacol.,
May 1, 2004;
65(5):
1051 - 1059.
[Abstract][Full Text]
E. N. Chini and F. G. S. De Toledo Nicotinic acid adenine dinucleotide phosphate: a new intracellular second messenger?
Am J Physiol Cell Physiol,
June 1, 2002;
282(6):
C1191 - C1198.
[Abstract][Full Text][PDF]
A. N.K. Yusufi, J. Cheng, M. A. Thompson, J. C. Burnett, and J. P. Grande Differential Mechanisms of Ca2+ Release from Vascular Smooth Muscle Cell Microsomes
Experimental Biology and Medicine,
January 1, 2002;
227(1):
36 - 44.
[Abstract][Full Text][PDF]